Gavreto (pralsetinib): Increased risk for tuberculosis and measures to minimise this risk
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
Carcinoma, Non-Small-Cell Lung
|Human ATC code||